HELNF
$298.65+20.18%
4/15, 4:11 AMHelvetia Baloise Holding AG (HLVTY) Q4 2025 Earnings Call Prepared Remarks Transcript
Helvetia Baloise Holding AG (HLVTY) Q4 2025 Earnings Call Prepared Remarks Transcript
seekingalpha.comView Stock →
Real-time ticker analysis, price-action alerts, and institutional-grade stock data.
Helvetia Baloise Holding AG (HLVTY) Q4 2025 Earnings Call Prepared Remarks Transcript
I reiterate a Strong Buy on Newmont Corporation due to its disciplined capital allocation and shareholder-friendly framework. NEM's enhanced capital allocation links sustaining/development capital, dividends, and balance sheet discipline, supporting robust free cash flow and consistent returns. The company maintains the industry's largest gold reserve base, with conservative reserve assumptions and significant upside if gold prices remain firm.
The copper miner's production declined 8% from the same period a year earlier, but it said expects to achieve its full-year guidance as output picks up.
German chip systems manufacturer Aixtron raised its revenue guidance for 2026 on Tuesday, propelled by strong demand for optoelectronics equipment, which sent its shares to an over two-year high on Wednesday.
Evolution Mining Limited (CAHPF) Q3 2026 Earnings Call Transcript
KAYAK spots an increase in European road trips among Brits ahead of May bank holidays and estimates cost of scenic drives with its Road Trip Calculator.
LONDON--(BUSINESS WIRE)---- $III #AI--Enterprises in Europe are adopting AI-native and software-defined digital engineering for innovation speed, compliance and sustainability, ISG says.
I am initiating Schwab U.S. Tips ETF as a strong buy, citing the most attractive TIPS setup since the 2023 real yield peak. SCHP offers a 4.74% SEC yield, 3.89% YTM, and monthly inflation accrual, all at a 3 bps expense ratio and institutional tradability. Current real yields near 1.94% present a rare entry point, with historical mean reversion suggesting likely yield declines and attractive total return potential.
Albertsons Companies is rated Buy, supported by robust cash flow, digital/pharma expansion, and significant cost-saving initiatives amid a challenging environment. ACI trades at an attractive valuation, with intrinsic value estimated well above current levels, implying significant levels of risk already priced in. FY26 guidance includes 0–1% identical sales growth and $3.85–$3.925 billion Adj. EBITDA and elevated CAPEX to drive digital and supply chain automation.
Japan said on Wednesday it would set up a financial framework worth about $10 billion to help Asian countries secure energy resources as the Middle East conflict has intensified competition to secure oil.
Rising geopolitical tensions, increasing budget deficits, and central bank buying have driven the prices of gold and silver higher. Wheaton Precious Metals' streaming business model gives it upside from rising prices while insulating it from rising costs.
Russia will continue helping fuel-hungry Cuba with crucial supplies of oil, Foreign Minister Sergei Lavrov said on Wednesday, two weeks after Moscow sent a tanker with around 700,000 barrels of crude to the Caribbean island.
Uber Technologies Inc (NYSE:UBER, XETRA:UT8) is intensifying competition with dedicated robotaxi operators by committing more than $10 billion to autonomous vehicle purchases and equity stakes in their developers, the Financial Times reported on Wednesday. The investment marks a significant shift away from the ride-hailing giant's traditional asset-light model, as the company moves to defend its position against the growing robotaxi threat.
Nvidia has 74% of its investment portfolio spread across Intel and CoreWeave. Intel's execution missteps have led to substantial market share losses in data center CPUs.
Poolbeg Pharma PLC (AIM:POLB, OTC:POLBF, FRA:POLBF), the AIM-listed clinical-stage biopharmaceutical company, has received clinical trial authorisation from...
ASML Holding NV (NASDAQ:ASML, XETRA:ASME), Europe's largest company by market capitalisation, has raised its full-year sales forecast and reported a sharp rise in first-quarter profits, as surging AI-related investment drives accelerating demand for its semiconductor manufacturing equipment. Shares were little changed on Wednesday, having already gained nearly 7% in the run-up to the results and 31% since the start of the year.
Stocks pause after yesterday's rally; Brent crude hovers around $95 a barrel
ASML raised its annual forecast, saying it now expects 2026 net sales will be between €36 billion and €40 billion. CNBC's Arjun Kharpal explains what is driving the Dutch chip giant's performance.
Thor Explorations Ltd (TSX-V:THX, AIM:THX, OTC:THXPF, FRA:T2X) has kept full-year guidance in place after pouring 20,256 ounces of gold in the first quarter...
BCS Wealth Management raised its stake in Vanguard Small-Cap Value ETF (NYSEARCA:VBR) by 102.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 7,237 shares of the company's stock after acquiring an additional 3,671 shares during the period. BCS
BCS Wealth Management raised its stake in shares of Innovator MSCI EAFE Power Buffer ETF - April (NYSEARCA:IAPR) by 99.7% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 52,226 shares of the company's stock after buying an additional 26,068 shares
BCS Wealth Management lifted its stake in Duke Energy Corporation (NYSE: DUK) by 95.1% during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 14,666 shares of the utilities provider's stock after buying an additional 7,150 shares during the quarter. BCS Wealth Management's holdings
BCS Wealth Management increased its holdings in shares of Vanguard Dividend Appreciation ETF (NYSEARCA:VIG) by 100.0% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 6,306 shares of the company's stock after acquiring an additional 3,153 shares
BCS Wealth Management increased its holdings in Chevron Corporation (NYSE: CVX) by 86.2% in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 9,872 shares of the oil and gas company's stock after purchasing an additional 4,570 shares during the period. BCS Wealth
BCS Wealth Management raised its holdings in shares of CocaCola Company (The) (NYSE: KO) by 103.6% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 20,340 shares of the company's stock after acquiring an additional 10,348 shares during the period.
Bernardo Wealth Planning LLC grew its holdings in Capital Group Core Plus Income ETF (NYSEARCA:CGCP) by 3.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,158,823 shares of the company's stock after purchasing an additional 33,508
Bingham Private Wealth LLC bought a new position in shares of Brookfield Corporation (NYSE: BN) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 36,317 shares of the company's stock, valued at approximately $1,667,000. Brookfield accounts for 1.4% of Bingham
Bingham Private Wealth LLC purchased a new position in shares of Philip Morris International Inc. (NYSE: PM) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 7,588 shares of the company's stock, valued at approximately $1,217,000. Philip Morris International comprises about
Bellevue Asset Management LLC lifted its stake in First Trust Enhanced Short Maturity ETF (NASDAQ: FTSM) by 17.8% during the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 70,339 shares of the company's stock after buying an additional 10,626 shares during
Bingham Private Wealth LLC purchased a new stake in Crh Plc (NYSE: CRH) in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 10,016 shares of the construction company's stock, valued at approximately $1,250,000. CRH accounts for about 1.0% of Bingham Private
Harmony Biosciences (NASDAQ: HRMY) executives outlined 2026 priorities at Needham and Company's Virtual Healthcare Conference, emphasizing continued growth for WAKIX and multiple late-stage pipeline readouts across sleep-wake and rare epilepsy indications. WAKIX outlook and commercial execution President and CEO Jeffrey Dayno said Harmony is "on track to achieve over $1 billion in net revenue for WAKIX
Bingham Private Wealth LLC purchased a new position in shares of Gilead Sciences, Inc. (NASDAQ: GILD) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 11,530 shares of the biopharmaceutical company's stock, valued at approximately $1,415,000. Gilead Sciences accounts for 1.2% of
Bingham Private Wealth LLC purchased a new stake in shares of iShares MBS ETF (NASDAQ: MBB) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 15,903 shares of the company's stock, valued at approximately $1,514,000. iShares MBS ETF comprises 1.3% of Bingham
Bingham Private Wealth LLC bought a new stake in Invesco Russell 1000 Equal Weight ETF (NYSEARCA:EQAL) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 45,218 shares of the company's stock, valued at approximately $2,380,000. Invesco Russell 1000 Equal Weight ETF
Geron (NASDAQ: GERN) executives used a presentation at the Needham Healthcare Conference to outline the company's early commercial trajectory for its telomerase inhibitor imetelstat (marketed as RYTELO) in lower-risk myelodysplastic syndromes (MDS), provide updated views on physician adoption dynamics, and discuss the ongoing Phase 3 myelofibrosis (MF) program. Commercial launch status and financial outlook President and
Bernardo Wealth Planning LLC acquired a new stake in InterDigital, Inc. (NASDAQ: IDCC) in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 3,862 shares of the Wireless communications provider's stock, valued at approximately $1,230,000. Other institutional investors have also modified their holdings of
Bingham Private Wealth LLC purchased a new position in International Business Machines Corporation (NYSE: IBM) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 6,082 shares of the technology company's stock, valued at approximately $1,802,000. International Business Machines accounts for 1.5%
Diane Garrett, president and CEO of Hycroft Mining (NASDAQ: HYMC), told attendees at the European Gold Forum that the company is repositioning the Hycroft Mine in northern Nevada from its legacy as an intermittently operating heap-leach producer into what she described as a growing story centered on newly identified high-grade systems. Two high-grade silver discoveries alongside
Bingham Private Wealth LLC purchased a new stake in AbbVie Inc. (NYSE: ABBV) in the undefined quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 5,019 shares of the company's stock, valued at approximately $1,147,000. AbbVie accounts for 0.9% of Bingham Private Wealth LLC's holdings,
Bingham Private Wealth LLC acquired a new position in shares of iShares 7-10 Year Treasury Bond ETF (NASDAQ: IEF) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 10,212 shares of the exchange traded fund's stock, valued at approximately $982,000. A
Esperion Therapeutics (NASDAQ: ESPR) outlined its commercial progress and strategic priorities at Needham and Company's 25th Annual Healthcare Conference, highlighting revenue growth, new clinical and guideline tailwinds for its cholesterol franchise, and the recent acquisition of Corstasis Therapeutics and its heart failure product Enbumyst. President and CEO Sheldon Koenig said the company has made significant strides
Bingham Private Wealth LLC bought a new stake in shares of Mastercard Incorporated (NYSE: MA) during the undefined quarter, according to the company in its most recent disclosure with the SEC. The fund bought 2,449 shares of the credit services provider's stock, valued at approximately $1,398,000. Mastercard makes up 1.2% of Bingham Private
ICU Medical (NASDAQ: ICUI) executives highlighted the company's evolution into what CEO Vivek Jain described as "the world's only pure-play infusion company" during a fireside chat at the 25th Annual Needham Healthcare Conference, while also addressing pricing dynamics, product roadmaps, macro pressures, and capital allocation priorities. Company evolution and investment positioning Jain said ICU Medical has
Bingham Private Wealth LLC acquired a new position in shares of SPDR Bloomberg 1-3 Month T-Bill ETF (NYSEARCA:BIL) during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 30,916 shares of the company's stock, valued at approximately
Bingham Private Wealth LLC bought a new position in CocaCola Company (The) (NYSE: KO) during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 13,769 shares of the company's stock, valued at approximately $963,000. Several other hedge funds have also modified
Celldex Therapeutics (NASDAQ: CLDX) executives used an appearance at H.C. Wainwright's annual Inflammation and Skin Disease Conference to highlight the company's late-stage plans for barzolvolimab, an anti-KIT monoclonal antibody being developed for chronic urticaria and other inflammatory skin diseases, and to outline upcoming clinical milestones across the pipeline. Barzolvolimab positioned as mast-cell depleting approach In response
Bingham Private Wealth LLC acquired a new position in shares of Chevron Corporation (NYSE: CVX) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 6,926 shares of the oil and gas company's stock, valued at approximately $1,056,000. A number
Bingham Private Wealth LLC acquired a new stake in shares of iShares 3-7 Year Treasury Bond ETF (NASDAQ: IEI) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 15,484 shares of the company's stock, valued at approximately $1,848,000. iShares 3-7 Year Treasury Bond